Andrey Semechkin
Net Worth

Last updated:

What is Andrey Semechkin net worth?

The estimated net worth of Dr. Andrey Semechkin is at least $1,643,717 as of 21 Jan 2019. He owns shares worth $726,227 as insider and has received compensation worth at least $917,490 in International Stem Cell Corporation.

What is the salary of Andrey Semechkin?

Dr. Andrey Semechkin salary is $53,970 per year as Co-Chairman & Chief Executive Officer in International Stem Cell Corporation.

How old is Andrey Semechkin?

Dr. Andrey Semechkin is 65 years old, born in 1960.

What stocks does Andrey Semechkin currently own?

As insider, Dr. Andrey Semechkin owns shares in one company:

Company Title Shares Price per share Total value
International Stem Cell Corporation (ISCO) Co-Chairman & Chief Executive Officer 4,034,594 $0.18 $726,227

What does International Stem Cell Corporation do?

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.

ISCO logo
ISCO
International Stem Cell Corporation
$0.18

Andrey Semechkin insider trading

International Stem Cell Corporation

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 599,222 $1.75 $1,048,639
Option
Common Stock 15,556 N/A N/A
Option
Stock Options (Right to Buy) 15,556 N/A N/A
Option
Stock Options (Right to Buy) 30,556 N/A N/A
Option
Common Stock 30,556 N/A N/A
Purchase
Common Stock 1,860,810 $1.75 $3,256,418
Purchase
Common Stock 3,200 $1.64 $5,248
Purchase
Common Stock 3,000 $1.69 $5,070
Purchase
Common Stock 500 $1.6 $800
Purchase
Common Stock 6,500 $1.66 $10,790
Purchase
Common Stock 2,100 $1.59 $3,339
Purchase
Common Stock 1,000 $1.5 $1,500
Purchase
Common Stock 5,000 $1.32 $6,600
Purchase
Common Stock 285,714 $1.75 $500,000
Purchase
Common Stock 200,000 $1.75 $350,000
Purchase
Common Stock 154,285 $1.75 $269,999
Purchase
Common Stock 215,000 $1.75 $376,250
Purchase
Series A Warrant (Right to Buy) 2,462,856 N/A N/A
Purchase
Series I-2 Preferred Stock 4,310 $1.75 $7,543
Purchase
Common Stock 5,894,214 $0.05 $265,240
Purchase
Common Stock 5,894,214 $0.06 $341,864
Purchase
Series A Warrant (Right to Buy) 5,894,214 N/A N/A
Purchase
Series H-2 Preferred Stock 380 $0.06 $24
Purchase
Common Stock 3,888,889 $0.09 $350,000
Purchase
Common Stock 5,000,000 $0.1 $500,000
Purchase
Common Stock 4,800,000 N/A N/A
Option
Common Stock 10,504,584 N/A N/A
Option
Series A Warrant (Right to Buy) 8,753,820 $0.15 $1,313,073
Purchase
Common Stock 2,870,000 $0.15 $430,500
Purchase
Common Stock 5,998,999 $0.15 $899,850
Purchase
Series A Warrant (Right to Buy) 5,998,999 $0.15 $899,850
Purchase
Common Stock Warrant (Right to Buy) 250,000 $0.2 $50,000
Purchase
Common Stock 500,000 $0.2 $100,000
Purchase
Common Stock 10,000,000 $0.2 $2,000,000
Purchase
Common Stock Warrant (Right to Buy) 5,000,000 $0.2 $1,000,000
Purchase
Series G Preferred Stock 5,000,000 $0.4 $2,000,000
Option
Common Stock 490,000 $0.59 $289,100
Option
Stock Option (Right to buy) 490,000 $0.59 $289,100
Option
Stock Option (Right to buy) 21,000 $0.49 $10,290
Option
Common Stock 21,000 $0.49 $10,290
Purchase
Class D Convertible Preferred Stock 3,817 $0.25 $954
Purchase
Class D Convertible Preferred Stock 3 $0.25 $1
Purchase
Class D Convertible Preferred Stock 10 $0.25 $3
Purchase
Class D Convertible Preferred Stock 10 $0.25 $3
Purchase
Class D Convertible Preferred Stock 10 $0.25 $3
Purchase
Class D Convertible Preferred Stock 10 $0.25 $3
Purchase
Class C Convertible Preferred Stock 1,300,000 $0.25 $325,000

International Stem Cell key executives

International Stem Cell Corporation executives and other stock owners filed with the SEC: